Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-56.31	369.58	846.00
Graham Fair Price	62.18	78438.00	48364.28
PEG	-84.07	0.03	-0.17
Price/Book	5.79	0.43	0.41
Price/Cash Flow	92.52	-16.45	8.54
Prices/Earnings	-51.85	4.42	9.18
Price/Sales	-44.10	1.16	2.08
Price/FCF	92.52	-16.45	8.54
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.85	1.00	1.25
Operating Margin	-19.85	1.00	1.25
ROA	134.30	< 0.005	< 0.005
ROE	0.01	0.02	119.70
ROIC	0.05	0.08	69.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.13	0.19	-31.91
Dividends QOQ	< 0.005	-0.87	-8742.11
EBIT QOQ	9.17	0.66	-92.81
EPS QOQ	-0.56	1.68	202.23
FCF QOQ	1.37	-1.60	16.69
Revenue QOQ	-0.42	1.07	157.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-32.80	0.00	inf
Days Sales Outstanding (DSO)	194.39	0.13	-99.93
Inventory Turnover	-2.74	0.00	inf
Debt/Capitalization	0.74	0.72	-2.43
Quick Ratio	0.57	0.68	19.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	96964.41	106096.53	9.42
Cash	245621.81	240553.60	-2.06
Capex	-370.82	-354.10	4.51
Free Cash Flow	4605.20	-2768.96	-39.87
Revenue	18950.22	39243.47	107.09
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.26	0.68	165.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	712.51	293.31	-58.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating